GIACOMINA SOREZZA: Open Payments
NPI 1861093221 · MANALAPAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,927 in 114 payments from 14 companies in 2025. Trend: 2023 $1,269 · 2024 $1,601 · 2025 $3,927
Food & beverage: $2,882Travel & lodging: $1,045
| Company | Payments | Amount |
|---|---|---|
| ConvaTec Inc. | 9 | $1,731 |
| AstraZeneca Pharmaceuticals LP | 14 | $664 |
| Novo Nordisk Inc | 30 | $465 |
| ABBVIE INC. | 26 | $363 |
| Amgen Inc. | 12 | $188 |
| GlaxoSmithKline, LLC. | 4 | $177 |
| Exact Sciences Corporation | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Lilly USA, LLC | 4 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
Products named: INNOVAMATRIX AC, BREZTRI, VRAYLAR, Ozempic, AIRSUPRA, AREXVY, KRYSTEXXA, Wegovy.
Industry payments across NJ — which companies pay providers there.
